<DOC>
	<DOCNO>NCT02248896</DOCNO>
	<brief_summary>The primary objective study ass whether increase risk sepsis use telmisartan compare ARBs major antihypertensive class , include ACEIs , beta-blockers , CCBs thiazide diuretic . A secondary objective ass whether use ARBs ACEIs , compare three major antihypertensive class untreated hypertension , associate increase risk sepsis . A third objective evaluate whether use telmisartan compare ARBs , ACEIs major antihypertensive class associate increase risk worse outcome due sepsis , particular acute kidney injury death</brief_summary>
	<brief_title>Antihypertensive Medications Risk Sepsis</brief_title>
	<detailed_description />
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<mesh_term>Enzyme Inhibitors</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<criteria>Patients , 18 year old , least twoyear followup United Kingdom 's general practice research database ( GPRD ) , diagnosis treatment hypertension Sepsis , chronic renal failure dialysis twoyear period prior cohort entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>